(Q27851554)

English

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

scientific article

  • FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
  • FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer

Statements

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer (English)
1 reference
0 references
0 references
0 references
Jorge S Reis-Filho
0 references
Nicholas Turner
0 references
Alex Pearson
0 references
Rachel Sharpe
0 references
Maryou Lambros
0 references
Felipe Geyer
0 references
Maria A Lopez-Garcia
0 references
Caterina Marchio
0 references
Alan Mackay
0 references
1 March 2010
0 references
70
0 references
2085-94
0 references
5
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit